Lung cancer: developments, concepts, and specific aspects of the new WHO classification

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 5, 2016, Pages 895-904

  Petersen, Iver ^a   Warth, Arne ^b,c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Member of the German Center for Lung Research   (Germany)

Author keywords

Classification; Diagnosis; Immunohistochemistry; Lung cancer; Molecular pathology

Indexed keywords

ADENOSQUAMOUS CARCINOMA; BASALOID CARCINOMA; CYTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG; LUNG CANCER; NON SMALL CELL LUNG CANCER; NUT MIDLINE CARCINOMA; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND TUMOR; SARCOMATOID CARCINOMA; SOFT TISSUE TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; TUMOR GROWTH; WORLD HEALTH ORGANIZATION; CANCER STAGING; CLASSIFICATION; LUNG TUMOR; PATHOLOGY;

HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM STAGING; WORLD HEALTH ORGANIZATION;

EID: 84937715917     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-015-2004-4     Document Type: Review

References (51)

1. Addis BJ, Dewar A, Thurlow NP (1988) Giant cell carcinoma of the lung—immunohistochemical and ultrastructural evidence of dedifferentiation. J Pathol 155:231–240
2. Antonescu CR, Le Loarer F, Mosquera JM et al (2013) Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosom Cancer 52:775–784
3. Brambilla E, Moro D, Veale D et al (1992) Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 23:993–1003
4. Bubendorf L (2011) Preneoplastic lesions of pulmonary carcinoma. Der Pathologe 32(Suppl 2):218–223
5. Cavazza A, Colby TV, Tsokos M et al (1996) Lung tumors with a rhabdoid phenotype. Am J Clin Pathol 105:182–188
6. Chejfec G, Candel A, Jansson DS et al (1991) Immunohistochemical features of giant cell carcinoma of the lung: patterns of expression of cytokeratins, vimentin, and the mucinous glycoprotein recognized by monoclonal antibody A-80. Ultrastruct Pathol 15:131–138
7. Chetty R, Bhana B, Batitang S et al (1997) Lung carcinomas composed of rhabdoid cells. Eur J Surg Oncol 23:432–434
8. Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150:12–27
9. Dawson MA, Kouzarides T, Huntly BJ (2012) Targeting epigenetic readers in cancer. New Engl J Med 367:647–657
10. Falconieri G, Moran CA, Pizzolitto S et al (2005) Intrathoracic rhabdoid carcinoma: a clinicopathological, immunohistochemical, and ultrastructural study of 6 cases. Ann Diagn Pathol 9:279–283
11. Fernandez-Cuesta L, Peifer M, Lu X et al (2014a) Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat Commun 5:3518
12. Fernandez-Cuesta L, Peifer M, Lu X et al (2014b) Cross-entity mutation analysis of lung neuroendocrine tumors sheds light into their molecular origin and identifies new therapeutic targets. In: Proceeding of the American Association for Cancer Research. Annual Meeting 2014, vol. 1531, San Diego, USA
13. Janssen-Heijnen ML, Coebergh JW (2001) Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 31:123–137
14. Junker K, Petersen I (2009) Small cell lung cancer: pathology and molecular pathology. Der Pathologe 30:131–140
15. Kadota K, Yeh YC, Sima CS et al (2014) The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 27:690–700
16. Kadota K, Nitadori JI, Sima CS et al (2015) Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences following limited resection for small stage I lung adenocarcinomas. J Thorac Oncol 10:806–814
17. Kaneko T, Honda T, Fukushima M et al (2002) Large cell carcinoma of the lung with a rhabdoid phenotype. Pathol Int 52:643–647
18. Knösel T, Heretsch S et al (2010) TLE1 is a robust biomarker for synovial sarcoma and correlates with t(X;18): analysis of 319 cases. Eur J Cancer 46(6):1170–1176
19. Kuroda M, Oka T, Horiuchi H et al (1994) Giant cell tumor of the lung: an autopsy case report with immunohistochemical observations. Pathol Int 44:158–163
20. Lewis DR, Check DP, Caporaso NE et al (2014) US lung cancer trends by histologic type. Cancer 120:2883–2892
21. Li Y, Linnoila RI (2012) Multidirectional differentiation of Achaete-Scute homologue-1-defined progenitors in lung development and injury repair. Am J Respir Cell Mol Biol 47:768–775
22. Linnoila RI (2006) Functional facets of the pulmonary neuroendocrine system. Lab Invest J Tech Methods Pathol 86:425–444
23. Marci V, Volante M, Cappia S et al (2007) Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma. Virchows Arch Int J Pathol 451:729–736
24. Mireskandari M, Abdirad A, Zhang Q et al (2013) Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung. Pathol Res Pract 209:578–584
25. Moreira AL, Joubert P, Downey RJ et al (2014) Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol 45:213–220
26. Moro-Sibilot D, Lantuejoul S, Diab S et al (2008) Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J 31:854–859
27. Nitsche K, Gunther B, Katenkamp D et al (2012) Thoracic neoplasms at the Jena reference center for soft tissue tumors. J Cancer Res Clin Oncol 138:415–424
28. Peifer M, Fernandez-Cuesta L, Sos ML et al (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44:1104–1110
29. Petersen I (2013) The new classification of lung adenocarcinoma. Zentralbl Chir 138(Suppl 1):S16–S24
30. Petersen I, Petersen S (2001) Towards a genetic-based classification of human lung cancer. Anal Cell Pathol 3:111–121
31. Petersen I, Kotb WF et al (2009) Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 65:312–318
32. Shimazaki H, Aida S, Sato M et al (2001) Lung carcinoma with rhabdoid cells: a clinicopathological study and survival analysis of 14 cases. Histopathology 38:425–434
33. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30
34. Stelow EB (2011) A review of NUT midline carcinoma. Head Neck Pathol 5:31–35
35. Tamboli P, Toprani TH, Amin MB et al (2004) Carcinoma of lung with rhabdoid features. Hum Pathol 35:8–13
36. Thunnissen E, Beasley MB, Borczuk AC et al (2012) Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol 25:1574–1583
37. Travis WD, Brambilla E, Müller-Hermeling K, Harris CC (2004) WHO classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart, 3rd edn. IARC Press, Lyon
38. Travis WD, Brambilla E, Noguchi M et al (2011) International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285
39. Travis WD, Brambilla E, Noguchi M et al (2013) Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 137:685–705
40. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) WHO classification of tumours of the lung, pleura, thymus and thymus, 4th edn. IARC, Lyon
41. Warth A, Herpel E, Schmahl A et al (2008) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report. J Med Case Rep 2:21
42. Warth A, Muley T, Meister M et al (2012a) The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30:1438–1446
43. Warth A, Cortis J, Fink L et al (2012b) Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch 461:185–193
44. Warth A, Stenzinger A, Von Brunneck AC et al (2012c) Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J 40:1221–1227
45. Warth A, Muley T, Herpel E et al (2012d) Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology 61:1017–1025
46. Warth A, Bubendorf L, Gutz S et al (2013a) Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing. Der Pathologe 34:310–317
47. Warth A, Stenzinger A, Weichert W (2013b) Novel morphological and molecular aspects of lung cancer. Der Pathologe 34:419–428
48. Warth A, Muley T, Kossakowski C et al (2015a) Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. J Thorac Oncol 10:638–644
49. Warth A, Muley T, Kossakowski C et al (2015b) Prognostic impact of intra-alveolar tumor spread in pulmonary adenocarcinoma. Am J Surg Pathol 39:793–801
50. Weichert W, Warth A (2014) Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma. Curr Opin Pulm Med 20:309–316
51. Yilmazbayhan D, Ates LE, Dilege S et al (2005) Pulmonary large cell carcinoma with rhabdoid phenotype. Ann Diagn Pathol 9:223–226